XVIVO is a medical animation and digital content studio where science meets storytelling. Our team of scientific experts, skilled artists, and seasoned storytellers specializes in transforming complex scientific concepts into compelling visual narratives. We create precise, visually stunning, and engaging digital assets—from 3D animations and illustrations to interactive experiences—designed to captivate and educate your audience.
XVIVO is committed to keeping our shared humanity at the heart of everything we do. This commitment inspires how we approach storytelling and how we work with you to bring these stories to life.
XVIVO shares your passion for scientific exploration. We immerse ourselves in your groundbreaking research to visualize the new perspective it reveals. We take our stewardship seriously knowing the impact these stories will have.
XVIVO understands the pressures and complexities of working in this industry: deadlines, medical regulations, the need to get the science right. That’s why we approach every project with care and respect. We are more than just creative partners; we lighten the load and help you sleep a little easier, knowing your vision is in good hands.
XVIVO’s commitment is an assurance that the work we develop for you—whether it’s a medical illustration, animation, or interactive experience—will effectively connect your science to your audience and inspire meaningful conversations.
Faber is a boutique law firm uniquely focused on the business of the life sciences community. Our team includes about 50 professionals, and we have worked with 2000+ clients in the life sciences, healthcare IT, medical devices, and engineering technology. The driving force of our practice is our focus on the business transactions that accelerate company growth, and the discovery, development and commercialization of therapeutics and related technologies.
Our twenty-six lawyers and eleven contracts’ specialists and paraprofessionals have deep expertise and broad experience, and extraordinary creative insight and keen judgment that can come only from having collectively provided counsel to over 2,000 companies, research institutions and investors in the life sciences and having successfully navigated thousands of transactions. We can quickly, and efficiently, recognize, prioritize, structure and document the key elements of acquisitions, licensing, collaboration, funding and other business transactions for these clients.
The firm maintains offices in Boston, New York, and San Francisco, and works with clients located or transacting business throughout the United States, Canada, Europe, Japan, China, Taiwan, Australia, India, Israel and, occasionally, other parts of the world.
We are a full-service leader consulting firm that specializes in providing customized commercial solutions to small start-ups in the cell and gene and biotech markets. Our team of experts have years of experience in business strategy and helping clients streamline their operations, increase their revenue, and maximize their future growth potential. From strategic sales and marketing planning to building sales teams, building out your GMP capabilities, we offer a wide range of services that are tailored to meet the unique needs of your business.
With over 25 years of experience, Diana Morales, Founder and a commercial expert, offers tailored solutions to help businesses navigate the complexities of these dynamic industries. We specialize in strategic planning, market analysis, operational optimization, building strong commercial teams, serving as your interim CCO, building sales plans, delivering measurable results that drive growth and success long term.
Grace’s Fine Chemical Manufacturing Services (FCMS) is a small molecule CDMO in North America, differentiated by extensive expertise and the ability to provide integrated solutions for the pharmaceutical and fine chemical industries.
Our fine chemical offerings enable us to be your fully integrated domestic partner for the development and manufacture of registered starting materials (RSMs), intermediates, and custom active pharmaceutical ingredients (APIs). Not only can we integrate into your RSM, but we can also partner with you from the lab all the way to commercial production and provide compliance leadership throughout the process.
Grace’s strategically located fine chemical facilities in Pennsylvania and Michigan are designed to meet customers’ quality, regulatory and confidentiality expectations.
Our capabilities include:
BioMarin is a global biotechnology company with eight marketed products that treat life-threatening conditions.
Since our founding in 1997, we’ve applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities. Our approved medicines treat achondroplasia, severe hemophilia A and several rare inherited and lysosomal storage diseases. We’re also advancing an industry-leading pipeline of investigational medicines that are in various stages of clinical and preclinical development.
Bartholomew Advisors is focused on executive search within Life Sciences for clients ranging from small private equity backed companies to the largest corporations in the world. We exclusively work on roles of critical importance to our clients. Typically, such roles include Chair, independent board directors, CEOs and heads of a function that report to a CEO, however any role that is mission critical for our clients would be undertaken. We advise public companies and, occasionally, charitable organizations.
Clients are based in the US and across Europe. A considerable number of our searches are North American in focus, many are pan-European and the rest, global. We are experts at advising on the challenges of international relocations.
For existing clients, we carry out market mapping projects to determine if an executive search is worthwhile. Our advice is impartial and expert.
As a boutique consultancy, we are less encumbered by the off-limit restrictions larger agencies operate under, so can focus on delivering you the perfect candidate for your position.
About HSBC Innovation Banking
We are specialists in the innovation economy, helping visionaries with entrepreneurial minds achieve their ambitions and beyond. We support clients and investors through all business life stages, from pre-Series A to post IPO, with our deep sector expertise, stability, and international reach. We work with the most innovative, venture-backed businesses and their investors across all life stages, within the technology, life sciences, and healthcare sectors. Visit us at: http://innovationbanking.hsbc
HSBC Holdings plc, the parent company of HSBC, is headquartered in London. HSBC serves customers worldwide from offices in 60 countries and territories. With assets of US$2,975bn at 30 June 2024, HSBC is one of the world’s largest banking and financial services organizations.
HSBC Bank USA, National Association (HSBC Bank USA, N.A.) serves customers through Wealth and Personal Banking, Commercial Banking, Private Banking, Global Banking, and Markets and Securities Services. Deposit products are offered by HSBC Bank USA, N.A., Member FDIC. It operates Wealth Centers in: California; Washington, D.C.; Florida; New Jersey; New York; Virginia; and Washington. HSBC Bank USA, N.A. is the principal subsidiary of HSBC USA Inc., a wholly-owned subsidiary of HSBC North America Holdings Inc.
We bring together the brightest minds in New England’s vibrant life sciences sectors, including biotechnology, pharmaceuticals, artificial intelligence, healthcare venture capital, data analytics, and precision medicine. Whether you’re looking to forge strategic partnerships, stay ahead of industry trends, or explore new markets, NEBCO is here to facilitate your growth. Our platform also connects startups and established businesses with venture capitalists and investors ready to support innovations across the bioscience and healthcare landscape.
We produce the NEBCO Leadership Conference, taking place on April 23-24, 2025, in New Haven, CT. This event serves as a convergence point for academia, industry leaders, healthcare providers, and investors, driving groundbreaking research and development while providing insight to New England’s flourishing bioscience industry. NEBCO is essential for companies looking to collaborate with New England’s bioscience and life science organizations. Our region is renowned for its synergistic environment that cultivates robust connections among academia, industry, and healthcare providers, establishing it as a hub for biomedical research and innovation. Attending the conference offers invaluable networking opportunities with key players and insights into the latest advancements in bioscience. This makes it a must-attend event for anyone eager to engage with and benefit from New England’s dynamic bioscience community.
Join us at NEBCO 2025 and be part of a community dedicated to shaping the future of healthcare and bioscience innovation! www.nebco.org
The Associated Construction Company was incorporated in New London, CT on August 4, 1942 by Angelo Giardini. The organization was originally founded as a military defense contractor and constructed various base facilities for the US Navy and its submarine base in Groton. With a growing need for housing, Associated Construction increasingly expanded into multi-residential construction. In 1946, Associated Construction relocated to Hartford, CT to broaden its client base, and its reputation for quality construction work in the areas of housing development, commercial offices, retail facilities, industrial plants, healthcare facilities, industrial structures and water sewage treatment plants quickly grew. Today, the firm is led by President Joseph Jankowski, and Vice President Kevin McConnell. Joe’s introduction to the industry began with the Associated Construction Company in 1984, and Kevin’s in 2021. Both leaders have been exposed to complex technical projects which have imparted a high level of skill, experience and management techniques. The diversity of positions held between them include field engineer, project engineer, superintendent, estimator, project manager and project executive, which enables them to continue to expand Associated Construction’s legacy of excellence.
The Associated Construction Company excels in constructing bio-technical, pharmacological, and pharmaceutical facilities. We prioritize collaboration with the entire project team from the onset of design development through to the commissioning of the facility. From the beginning, we engage with the owner and design team to evaluate the overall project, considering its impact on surrounding areas, the importance of maintaining ongoing operations, and best practices for ensuring the highest quality construction. Safety is at the forefront of our planning and execution, ensuring that all protocols are strictly followed to protect everyone involved.
We then develop an action plan that integrates project-specific logistics with design requirements, always keeping safety as a top priority. We employ various procurement strategies to mitigate potential risks associated with different design and construction methodologies. We select subcontractor trade partners with a proven track record in complex projects and familiarity with sophisticated engineering systems to ensure successful and safe project completion.
The Associated Construction Company was incorporated in New London, CT on August 4, 1942 by Angelo Giardini. The organization was originally founded as a military defense contractor and constructed various base facilities for the US Navy and its submarine base in Groton. With a growing need for housing, Associated Construction increasingly expanded into multi-residential construction. In 1946, Associated Construction relocated to Hartford, CT to broaden its client base, and its reputation for quality construction work in the areas of housing development, commercial offices, retail facilities, industrial plants, healthcare facilities, industrial structures and water sewage treatment plants quickly grew. Today, the firm is led by President Joseph Jankowski, and Vice President Kevin McConnell. Joe’s introduction to the industry began with the Associated Construction Company in 1984, and Kevin’s in 2021. Both leaders have been exposed to complex technical projects which have imparted a high level of skill, experience and management techniques. The diversity of positions held between them include field engineer, project engineer, superintendent, estimator, project manager and project executive, which enables them to continue to expand Associated Construction’s legacy of excellence.
The Associated Construction Company excels in constructing bio-technical, pharmacological, and pharmaceutical facilities. We prioritize collaboration with the entire project team from the onset of design development through to the commissioning of the facility. From the beginning, we engage with the owner and design team to evaluate the overall project, considering its impact on surrounding areas, the importance of maintaining ongoing operations, and best practices for ensuring the highest quality construction. Safety is at the forefront of our planning and execution, ensuring that all protocols are strictly followed to protect everyone involved.
We then develop an action plan that integrates project-specific logistics with design requirements, always keeping safety as a top priority. We employ various procurement strategies to mitigate potential risks associated with different design and construction methodologies. We select subcontractor trade partners with a proven track record in complex projects and familiarity with sophisticated engineering systems to ensure successful and safe project completion.